Journal Home
Search for

Volume 29, Issue 6, Pages 665-671 (June 2005)


View previous. 14 of 23 View next.

Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival

On behalf of the Intergroupe Francophone du Myelome (IFM)Xavier LeleuaCorresponding Author Informationemail address, Franck Genevievec, Romain Guiezea, Alain Duhamelb, Joris Andrieuxd, Celine Berthona, Alban Godonc, Sophie Prat-Lesaffrec, Stephane Depila, Jean-Luc Laid, Thierry Facona, Marc Zandeckic

Received 26 October 2004; received in revised form 16 December 2004; accepted 22 December 2004.

Abstract 

Morphological changes of plasma cells (PC) are common in multiple myeloma (MM). Loss of round or oval nuclear shape has been related to cell malignancy in human, and we looked for the occurrence of such morphological change on PC from bone marrow (BM) smears in a retrospective series of 169 MM patients at diagnosis. Nuclear shape changes of PC differed according to the patients (notch, dumb-bell, folded or monocytoid appearance), even in the same patient; all subtypes were pooled and defined as PC with irregular nuclear shape (PCIN). A significant number of PCIN (≥5% of all BMPC) was found at diagnosis in 20.7%. Median survival was of 22 months for patients with ≥5% PCIN, and 41 months for others (p=0.0001). Significant relationship was observed with prognostic parameters related intrinsic malignancy of the tumour process but not with beta-2-microglobulin (b2m). A clear-cut relationship was found also between PCIN and hypodiploidy (p=0.0001), but not with deletion of chromosome 13. This study emphasises the relationship between PCIN, an easy-to-ascertain marker of intrinsic malignancy of the tumour process, and adverse prognosis.

a Service des Maladies du Sang, CHU Lille, France

b Service de Biostatistique, CHU Lille, France

c Laboratoire d’Hematologie and UPRES EA-3863 “analyse des déterminants de la réponse immunitaire”, CHU Angers, France

d Service de Genetique Medicale, CHU Lille, France

Corresponding Author InformationCorresponding author. Tel.: +33 3 20 44 57 13; fax: +33 3 20 44 47 08.

PII: S0145-2126(05)00020-2

doi:10.1016/j.leukres.2004.12.002


View previous. 14 of 23 View next.